Musso Alan A 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Dec 13, 2017
Insider Transaction Report
Form 4
Musso Alan A
CFO and Treasurer
Transactions
- Sale
Common Stock
2017-12-11$9.33/sh−17,117$159,667→ 31,585 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on June 7, 2017.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.13 to $9.52. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth above.